I looked at the newly formed transition COVID advisory board, and looks like a decent list of professionals. Several with ties to the HIV and immunology field, so maybe they've heard of CytoDyn and Leronlimab already. Also, a couple of them have ties to UCSF School of Medicine in San Francisco, so maybe they know Dr. Jay and he can get into their ear. The best news is that at first glance, none of them work for Gilead!

I really hope we are kicking ass on enrollment...we need to get this done yesterday!